共 50 条
- [1] Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology GuidelineJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3673 - +Leighl, Natasha B.Rekhtman, NatashaBiermann, William A.Huang, JamesMino-Kenudson, MariRamalingam, Suresh S.West, HowardWhitlock, SaraSomerfield, Mark R.
- [2] Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline UpdateJOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (09) : 911 - +Kalemkerian, Gregory P.Narula, NavneetKennedy, Erin B.Biermann, William A.Donington, JessicaLeighl, Natasha B.Lew, MadelynPantelas, JamesRamalingam, Suresh S.Reck, MartinSaqi, AnjaliSimoff, MichaelSingh, NavneetSundaram, Baskaran
- [3] Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement Summary of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline UpdateJOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (05) : 323 - +Kalemkerian, Gregory P.Narula, NavneetKennedy, Erin B.
- [4] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyJOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 823 - 859Lindeman, Neal I.Cagle, Philip T.Beasley, Mary BethChitale, Dhananjay ArunDacic, SanjaGiaccone, GiuseppeJenkins, Robert BrianKwiatkowski, David J.Saldivar, Juan-SebastianSquire, JeremyThunnissen, ErikLadanyi, Marc
- [5] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyJOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (04): : 415 - 453Lindeman, Neal I.Cagle, Philip T.Beasley, Mary BethChitale, Dhananjay ArunDacic, SanjaGiaccone, GiuseppeJenkins, Robert BrianKwiatkowski, David J.Saldivar, Juan-SebastianSquire, JeremyThunnissen, ErikLadanyi, Marc
- [6] Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular PathologyJOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (02): : 129 - 159Lindeman, Neat I.Cagle, Philip T.Aisner, Dara L.Arcila, Maria E.Beasley, Mary BethBernicker, Eric H.Colasacco, CarolDacic, SanjaHirsch, Fred R.Kerr, KeithKwiatkowski, David J.Ladanyi, MarcNowak, Jan A.Sholl, LynetteTemple-Smolkin, RobynSolomon, BenjaminSouter, Lesley H.Thunnissen, ErikTsao, Ming S.Ventura, Christina B.Wynes, Murry W.Yatabe, Yasushi
- [7] Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular PathologyARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (03) : 321 - 346Lindeman, Neal I.Cagle, Philip T.Aisner, Dara L.Arcila, Maria E.Beasley, Mary BethBernicker, Eric H.Colasacco, CarolDacic, SanjaHirsch, Fred R.Kerr, KeithKwiatkowski, David J.Ladanyi, MarcNowak, Jan A.Sholl, LynetteTemple-Smolkin, RobynSolomon, BenjaminSouter, Lesley H.Thunnissen, ErikTsao, Ming S.Ventura, Christina B.Wynes, Murry W.Yatabe, Yasushi
- [8] Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular PathologyJOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) : 323 - 358Lindeman, Neal I.Cagle, Philip T.Aisner, Dara L.Arcila, Maria E.Beasley, Mary BethBernicker, Eric H.Colasacco, CarolDacic, SanjaHirsch, Fred R.Kerr, KeithKwiatkowski, David J.Ladanyi, MarcNowak, Jan A.Sholl, LynetteTemple-Smolkin, RobynSolomon, BenjaminSouter, Lesley H.Thunnissen, ErikTsao, Ming S.Ventura, Christina B.Wynes, Murry W.Yatabe, Yasushi
- [9] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (vol 8, pg 823, 2013)JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (10) : 1343 - 1343Lindeman, N., ICagle, P. T.Beasley, M. B.Chitale, D. A.Dacic, S.Giaccone, G.Jenkins, R. B.Kwiatkowski, D. J.Saldivar, J. S.Squire, J.Thunnissen, E.Ladanyi, M.
- [10] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (vol 137, pg 828, 2013)ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (06) : 1174 - 1174Lindeman, N., ICagle, P. T.Beasley, M. B.